4.6 Review

Up to What Extent Does Dravet Syndrome Benefit From Neurostimulation Techniques?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study

A. M. Drewes et al.

Summary: In patients with active rheumatoid arthritis, transcutaneous non-invasive vagus nerve stimulation (n-VNS) showed anti-inflammatory effects by reducing disease activity scores, C-reactive protein levels, and interferon-gamma. However, in patients with inactive disease, n-VNS did not affect disease activity scores, but led to a decrease in cardiac vagal tone and interleukin-10 levels.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2021)

Review Pharmacology & Pharmacy

Advances in the design and discovery of novel small molecule drugs for the treatment of Dravet Syndrome

Barbara Miziak et al.

Summary: Dravet syndrome is a severe form of epilepsy that starts in infancy, characterized by seizures triggered by high fever. It has a progression of worsening and stabilization stages, with most patients having a mutation in the SCN1A gene. Current treatment options include various drugs under clinical evaluation for potential efficacy.

EXPERT OPINION ON DRUG DISCOVERY (2021)

Review Clinical Neurology

The role of surgery in the management of Lennox-Gastaut syndrome: A systematic review and meta-analysis of the clinical evidence

Vineeth Thirunavu et al.

Summary: In this meta-analysis, it was found that corpus callosotomy (CC) appeared to be more effective than vagus nerve stimulation (VNS) for reducing seizures. VNS may provide similar or higher levels of quality of life improvement with lower aggregate risk of complications. Patient selection, anatomy, and seizure type are important factors in decision-making.

EPILEPSIA (2021)

Article Medicine, Research & Experimental

Deep Brain Stimulation for Refractory Focal Epilepsy: Unraveling the Insertional Effect up to Five Months Without Stimulation

Dominik Thuberg et al.

Summary: After electrode implantation, a reduction in seizure frequency was observed in patients with focal epilepsy before stimulation initiation, suggesting the occurrence of an insertional effect (IE). The reduction in seizure frequency was found to be independent of the number of implanted electrodes and the stimulation target, with the peak of the lesional effect occurring at two to three months after electrode insertion in a subgroup of epilepsy patients.

NEUROMODULATION (2021)

Article Clinical Neurology

Two-center experience of cannabidiol use in adults with Dravet syndrome

Katri Silvennoinen et al.

Summary: In two UK neurology centres, 18 adults with Dravet Syndrome were treated with cannabidiol (CBD), with some experiencing a significant reduction in convulsive seizures, although a relatively high rate of adverse events was observed.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)

Review Clinical Neurology

SCN1A Mutation-Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis

Jiangwei Ding et al.

Summary: SCN1A mutations are not only associated with Dravet syndrome, but also with various other epileptic encephalopathies and related disorders.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Network Substrates of Centromedian Nucleus Deep Brain Stimulation in Generalized Pharmacoresistant Epilepsy

Cristina V. Torres Diaz et al.

Summary: Deep brain stimulation (DBS), particularly thalamic DBS, has shown promising results in reducing seizure severity and frequency in pharmacoresistant epilepsies. This study revealed that the clinical outcome of CM-DBS in generalized pharmacoresistant epilepsy is highly dependent on individual connectivity profiles and involves cerebello-thalamo-cortical circuits, offering potential implications for personalized neuromodulation and refining stereotactic implantation in the future.

NEUROTHERAPEUTICS (2021)

Article Clinical Neurology

Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial

Ingrid E. Scheffer et al.

Summary: Long-term treatment with cannabidiol (CBD) showed acceptable safety and significant reductions in seizure frequency for patients with treatment-resistant Dravet syndrome.

EPILEPSIA (2021)

Article Clinical Neurology

Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials

Jennifer Madan Cohen et al.

Summary: This study conducted post hoc analysis of two randomized controlled trials on the time to onset of cannabidiol (CBD) treatment effects in patients with Dravet syndrome. The results suggest that therapeutic effects of CBD may start within 2 weeks of treatment in some patients. Although adverse events of CBD treatment lasted longer than placebo, most resolved within the 14-week study period.

EPILEPSIA (2021)

Article Behavioral Sciences

Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome

Kim I. Bishop et al.

Summary: In children and young adults with DS, reduction in seizure frequency after long-term treatment with adjunctive fenfluramine was associated with clinically meaningful improvements in everyday executive functions. 78% of children and young adults achieved a >= 50% reduction in seizure frequency, which was significantly associated with greater likelihood of clinically meaningful improvement in emotion regulation and cognitive regulation.

EPILEPSY & BEHAVIOR (2021)

Article Clinical Neurology

Long-term results of vagus nerve stimulation in children with Dravet syndrome: Time-dependent, delayed antiepileptic effect

Song Ee Youn et al.

Summary: The study aimed to evaluate the long-term outcomes of vagus nerve stimulation (VNS) in children with pharmaco-resistant Dravet syndrome (DS). Results showed that VNS therapy led to long-term, progressive, and time-dependent improvement in seizure control for children with pharmaco-resistant DS.

EPILEPSY RESEARCH (2021)

Review Clinical Neurology

Is vagal-nerve stimulation safe during pregnancy? A mini review

Jiangwei Ding et al.

Summary: Vagus-nerve stimulation (VNS) may have little effect on pregnancy, with research indicating that it can be relatively safe and effective for both the fetus and mother during pregnancy. Further studies with larger sample sizes and longer follow-up periods are needed to confirm these findings.

EPILEPSY RESEARCH (2021)

Review Clinical Neurology

New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol

V. Villanueva et al.

Summary: Dravet syndrome and Lennox-Gastaut syndrome are two serious epileptic syndromes with pediatric onset that are resistant to treatment, leading to increased mortality rates and comorbidities; oral solution cannabidiol is considered an innovative therapy that can better control the seizures and convulsions associated with these syndromes, but may also cause some adverse effects.

REVISTA DE NEUROLOGIA (2021)

Review Behavioral Sciences

Intellectual functioning and behavior in Dravet syndrome: A systematic review

Josefine Soto Jansson et al.

EPILEPSY & BEHAVIOR (2020)

Review Behavioral Sciences

Vagus nerve stimulation and Neurotrophins: a biological psychiatric perspective

Pamela Rosso et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)

Letter Clinical Neurology

Studies of deep brain stimulation in Parkinson's disease

Jerrold L. Vitek et al.

LANCET NEUROLOGY (2020)

Article Clinical Neurology

Efficacy of the ketogenic diet in patients with Dravet syndrome: A meta-analysis

Yan-Qiu Wang et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)

Review Clinical Neurology

Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: A critical review

Denahin Hinnoutondji Toffa et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)

Article Clinical Neurology

Cortical disinhibition in Parkinson's disease

Claudia Ammann et al.

Article Behavioral Sciences

Cognitive, behavioral,and social functioning in children and adults with Dravet syndrome

Amy Brown et al.

EPILEPSY & BEHAVIOR (2020)

Article Clinical Neurology

Brain-responsive neurostimulation for epilepsy (RNS® System)

Tara L. Skarpaas et al.

EPILEPSY RESEARCH (2019)

Review Clinical Neurology

Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy

Debopam Samanta

PEDIATRIC NEUROLOGY (2019)

Article Clinical Neurology

Vagus Nerve Stimulation for the Treatment of Epilepsy

Herman F. J. Gonzalez et al.

NEUROSURGERY CLINICS OF NORTH AMERICA (2019)

Article Multidisciplinary Sciences

Hippocampal deletion of NaV1.1 channels in mice causes thermal seizures and cognitive deficit characteristic of Dravet Syndrome

Rachael E. Stein et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Clinical Neurology

The Efficacy of Ketogenic Diet in 60 Chinese Patients With Dravet Syndrome

Xiaojuan Tian et al.

FRONTIERS IN NEUROLOGY (2019)

Review Clinical Neurology

Recent Advances in the Drug Treatment of Dravet Syndrome

Elaine C. Wirrell et al.

CNS DRUGS (2019)

Review Pharmacology & Pharmacy

Stiripentol: A Review in Dravet Syndrome

James E. Frampton

Article Clinical Neurology

Dravet syndrome: Treatment options and management of prolonged seizures

J. Helen Cross et al.

EPILEPSIA (2019)

Review Clinical Neurology

Deep brain stimulation for drug-resistant epilepsy

Michael C. H. Li et al.

EPILEPSIA (2018)

Article Medicine, General & Internal

Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome

Orrin Devinsky et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Clinical Neurology

Deep brain stimulation for seizure control in drug-resistant epilepsy

Neil Klinger et al.

NEUROSURGICAL FOCUS (2018)

Review Clinical Neurology

Dravet syndrome and its mimics: Beyond SCN1A

Dora Steel et al.

EPILEPSIA (2017)

Review Behavioral Sciences

Cannabinoids in treatment-resistant epilepsy: A review

Brooke K. O'Connell et al.

EPILEPSY & BEHAVIOR (2017)

Review Clinical Neurology

Chronic subthreshold cortical stimulation: a therapeutic and potentially restorative therapy for focal epilepsy

Brian Nils Lundstrom et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)

Article Clinical Neurology

Vagus Nerve Stimulation in Intractable Epilepsy Associated With SCN1A Gene Abnormalities

Stephen P. Fulton et al.

JOURNAL OF CHILD NEUROLOGY (2017)

Editorial Material Clinical Neurology

Epilepsy Cannabidiol reduces seizure frequency in Dravet syndrome

Charlotte Ridler

NATURE REVIEWS NEUROLOGY (2017)

Review Clinical Neurology

Vagal Nerve Stimulation for Treatment-Resistant Depression

Flavia R. Carreno et al.

NEUROTHERAPEUTICS (2017)

Letter Medicine, General & Internal

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Rongrui Tang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Clinical Neurology

Efficacy of adjunctive vagus nerve stimulation in patients with Dravet syndrome: A meta-analysis of 68 patients

Maxine Dibue-Adjei et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)

Review Clinical Neurology

Chronic subthreshold cortical stimulation: a therapeutic and potentially restorative therapy for focal epilepsy

Brian Nils Lundstrom et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)

Review Clinical Neurology

Stiripentol in the Management of Epilepsy

Katherine C. Nickels et al.

CNS DRUGS (2017)

Review Clinical Neurology

Dravet Syndrome: Diagnosis and Long-Term Course

Mary B. Connolly

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)

Review Clinical Neurology

Palliative epilepsy surgery in Dravet syndrome-case series and review of the literature

Brian J. Dlouhy et al.

CHILDS NERVOUS SYSTEM (2016)

Letter Medicine, General & Internal

Cannabinoids in the Treatment of Epilepsy

Joep Killestein

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Pediatrics

Vagal Nerve Stimulation: Is It Effective in Children with Dravet Syndrome?

Deepa Sirsi et al.

JOURNAL OF PEDIATRIC EPILEPSY (2016)

Article Clinical Neurology

Vagus nerve stimulation in children less than 3 years with medically intractable epilepsy

Luis Fernandez et al.

EPILEPSY RESEARCH (2015)

Article Medicine, Research & Experimental

Sudden unexpected death in a mouse model of Dravet syndrome

Franck Kalume et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Gastroenterology & Hepatology

Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway

B. Bonaz et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2013)

Article Emergency Medicine

Feasibility of Percutaneous Vagus Nerve Stimulation for the Treatment of Acute Asthma Exacerbations

James R. Miner et al.

ACADEMIC EMERGENCY MEDICINE (2012)

Article Clinical Neurology

Stiripentol In Severe Myoclonic Epilepsy of Infancy (Dravet Syndrome)

Greg L. Plosker

CNS DRUGS (2012)

Editorial Material Substance Abuse

New neurostimulation techniques in adicctions

Mauro Garcia-Toro et al.

ADICCIONES (2011)

Article Clinical Neurology

Vagus nerve stimulation: effectiveness and tolerability in patients with epileptic encephalopathies

Ricardo O. Cersosimo et al.

CHILDS NERVOUS SYSTEM (2011)

Article Clinical Neurology

Nonpharmacologic treatments of Dravet syndrome: Focus on the ketogenic diet

Roberto Horacio Caraballo

EPILEPSIA (2011)

Article Clinical Neurology

The genetics of Dravet syndrome

Carla Marini et al.

EPILEPSIA (2011)

Article Clinical Neurology

Clinical course of young patients with Dravet syndrome after vagal nerve stimulation

Nelia Zamponi et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2011)

Article Clinical Neurology

Dravet syndrome and deep brain stimulation: Seizure control after 10 years of treatment

Danielle M. Andrade et al.

EPILEPSIA (2010)

Article Clinical Neurology

Stiripentol open study in Japanese patients with Dravet syndrome

Yushi Inoue et al.

EPILEPSIA (2009)

Article Genetics & Heredity

Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients

C. Depienne et al.

JOURNAL OF MEDICAL GENETICS (2009)

Article Clinical Neurology

Vagus nerve stimulation in pediatric epileptic syndromes

E. Rossignol et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2009)

Review Clinical Neurology

Surgery and electrical stimulation in epilepsy -: Selection of candidates and results

Vicente Villanueva et al.

NEUROLOGIST (2007)

Article Clinical Neurology

Ketogenic diet in patients with Dravet syndrome

RH Caraballo et al.

EPILEPSIA (2005)

Article Neurosciences

The antidepressant properties of the ketogenic diet

P Murphy et al.

BIOLOGICAL PSYCHIATRY (2004)